Degenerative Diseases, Central Nervous System
|
0.300 |
Biomarker
|
group |
CTD_human |
Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy.
|
15964507 |
2005 |
Degenerative Diseases, Spinal Cord
|
0.300 |
Biomarker
|
group |
CTD_human |
Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy.
|
15964507 |
2005 |
Down Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome.
|
11771762 |
2001 |
Down Syndrome, Partial Trisomy 21
|
0.300 |
Biomarker
|
disease |
CTD_human |
Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome.
|
11771762 |
2001 |
Trisomy 21, Meiotic Nondisjunction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome.
|
11771762 |
2001 |
Trisomy 21, Mitotic Nondisjunction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome.
|
11771762 |
2001 |
Hypertensive disease
|
0.250 |
GeneticVariation
|
group |
BEFREE |
Glutathione S-Transferase M1 and T1 polymorphisms and hypertension risk: an updated meta-analysis.
|
30420646 |
2019 |
Hypertensive disease
|
0.250 |
GeneticVariation
|
group |
BEFREE |
Some studies have recently focused on the association between glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms and hypertension; however, results have been inconsistent.
|
25742618 |
2015 |
Hypertensive disease
|
0.250 |
GeneticVariation
|
group |
BEFREE |
Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies.
|
24788870 |
2014 |
Hypertensive disease
|
0.250 |
GeneticVariation
|
group |
BEFREE |
Glutathione S-transferase M1 and T1 gene polymorphisms and risk of hypertension in tea garden workers of North-East India.
|
21728793 |
2011 |
Hypertensive disease
|
0.250 |
Biomarker
|
group |
RGD |
In parallel, Western blotting and RT-PCR showed a similar reduction of GSTM2 in left ventricles and aortas of 4-, 8-, and 16-week-old SHR, which is before the onset of hypertension.
|
18008142 |
2008 |
Hypertensive disease
|
0.250 |
GeneticVariation
|
group |
BEFREE |
We then genotyped 753 trios from the Medical Research Council British Genetics of Hypertension Study transmission disequilibrium test cohort for 10 single nucleotide polymorphisms and the GSTM1 deletion and examined renal GSTM expression in a cohort of 27 hypertensive and 18 normotensive subjects.
|
18551009 |
2008 |
Hypertensive disease
|
0.250 |
Biomarker
|
group |
RGD |
Microarray analysis of rat chromosome 2 congenic strains.
|
12624007 |
2003 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer.
|
30032483 |
2018 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Association analysis identifies 65 new breast cancer risk loci.
|
29059683 |
2017 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Glutathione S-transferase M1, T1, and P1 genotypes and breast cancer risk: a study in a Portuguese population.
|
21559761 |
2011 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients.
|
21431478 |
2011 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.
|
19936916 |
2010 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, SNPs/haplotypes in the GSTM3 gene within the GSTMs gene cluster are likely to contribute to breast cancer risk when the GSTM1 is absent.
|
19856098 |
2010 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We genotyped GSTA2_448_C > G (rs2180314), GSTA2_742_A > C (rs6577), GSTM2_-832_T > C (rs638820), GSTO1_-1242_G > A (rs2164624), GSTO1_419_A > C (rs4925), GSTO2_-183_A > G (rs2297235), GSTO2_342_A > G (rs156697), GSTZ1_-4378_A > G (rs1046428), and GSTZ1_94_G > A (rs3177427) by MALDI-TOF MS in the German GENICA breast cancer case-control collection of 1021 cases and 1015 controls and performed breast cancer risk association in general and with respect to the stratifications: menopausal status, family history of breast or ovarian cancer, use of oral contraceptives, use of hormone therapy, body mass index, and smoking as well as histopathological tumor characteristics including hormone receptor status, grade, histology, and node status.
|
19859803 |
2010 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women.
|
17624589 |
2008 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers.
|
18542066 |
2008 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
|
16758119 |
2006 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis.
|
15344211 |
2004 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk.
|
14973116 |
2004 |